Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Adaptimmune Ther Ads (ADAP)

$3.66 0.00 (0.00%)

4:33 EST ADAP Stock Quote Delayed 15 Minutes

Volume:

Previous Close $3.66

Market Cap 344.56M

PE Ratio -5.08

EPS -0.72

Volume (Avg. Vol.) 6

Day's Range 3.66 - 3.66

52-Week Range 0.71 - 6.00

Dividend & Yield N/A (N/A)

ADAP Stock Predictions, Articles, and Adaptimmune Ther Ads News

From the Web

Adaptimmune Therapeutics (ADAP) Receives a Hold from JonesTrading

From Analyst Ratings Feb 27, 2020

In a report released today, Soumit Roy from JonesTrading reiterated a Hold rating on Adaptimmune Therapeutics (ADAP – Research Report). The company’s shares closed last Monday at $3.57. According to TipRanks.com, Roy is a 4-star analyst with an average return of 16.2% and a 37.8% success rate. Roy covers the Healthcare sector, focusing on stocks

The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy

From Benzinga Feb 27, 2020

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 26.) Co-...

Adaptimmune EPS beats by $0.27, misses on revenue

From Seeking Alpha Feb 27, 2020

Adaptimmune (NASDAQ:ADAP): Q4 GAAP EPS of -$0.05 beats by $0.27.Revenue of $0.73M (-50.7% Y/Y) misses by $0.79M.Press Release

How Does Adaptimmune Therapeutics plc (NASDAQ:ADAP) Affect Your Portfolio Volatility?

From Simply Wall St Feb 24, 2020

If you own shares in Adaptimmune Therapeutics plc (NASDAQ:ADAP) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adap/adaptimmune-therapeutics/news/how-does-adaptimmune-therapeutics-plc-nasdaqadap-affect-your-portfolio-volatility/">Read More...</a></div>

The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace

From Benzinga Feb 23, 2020

Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a...

New finance chief at Adaptimmune

From Seeking Alpha Feb 18, 2020

Adaptimmune Therapeutics (ADAP +1.2%) appoints Gavin Wood as Chief Financial Officer effective April 1. He joins the company from Abcam plc where he was also CFO.